Skip to main content
. 2019 Aug 20;9:12132. doi: 10.1038/s41598-019-48430-8

Figure 3.

Figure 3

The HPLC profile of the components in GHE was monitored at 265 nm and compared with that of nine standard compounds. (A) Structures of the nine components of GHE: 1, Gallic acid; 2, Protocatechuic acid; 3, Corilagin; 4, GN; 5, Ellagic acid; 6, Kaempferitrin; 7, Kaempferol-7-O-rhamnoside; 8, Quercetin; 9, Kaempferol. (B) HPLC profile of 5 mg/mL GHE and standard compounds. Measurement of the antiviral activity of GHE components (100 μM) using neuraminidase inhibition assay. The influenza A viruses H1N1 (C), A/PR/8/34 (D), and H3N2 (E) were added to the indicated concentrations of GHE components. Fluorescence was measured using fluorescence spectrophotometry (excitation, 365 nm and emission, 415–445 nm). Bar graph (mean ± SEM) statistics were determined by three experiments’ data using one-way ANOVA with Tukey’s post-hoc test, ***P < 0.001; *P < 0.05, compared with the CON (GHE untreated) samples. GA, Gallic acid; PA, Protocatechuic acid, CA, Corilagin; GN, Geraniin; EA, Ellagic acid; KPT, Kaempferitrin; KP-7-O-R, Kaempferol 7-O-rhamnoside; QC, Quercetin; KP, Kaempferol.